1 day ago
Partnership aims to transform HIV patient care with digital services
1 day ago
Therapy approved for the treatment of paediatric patients with anaplastic large cell lymphoma
1 day ago
Lead asset REX-001 is in Phase III development for chronic limb-threatening ischaemia
1 day ago
Approval is based on results from the Phase III DESTINY-Gastric01 trial
4 days ago
Agreement will leverage Enara's novel Dark Antigen discovery platform
4 days ago
Ensinfentrine is a first-in-class inhaled inhibitor of the enzymes phosphodiesterase 3 and 4
4 days ago
In a Phase IIb trial, more patients experienced complete resolution of hives with ligelizumab compared to Xolair
4 days ago
Zejula has been recommended for use in newly diagnosed ovarian cancer patients
5 days ago
Qualified pharmacists will administer the Pfizer/BioNTech vaccine at an in-store pharmacy
5 days ago
First dispersible tablet formulation of Tivicay now available for children in the EU
5 days ago
Oxford Immunotec will perform T cell testing on participants receiving Valneva's vaccine candidate
5 days ago
Companies will collaborate on a combination therapy study
6 days ago
Updated analysis is from the Phase III IMbrave150 study
6 days ago
MHRA submission is based on same application filed with the EMA
6 days ago
Investigational antibody targets a modified form of beta amyloid called N3pG
6 days ago
First patient in global trial dosed in the UK
1 week ago
Study will evaluate the role of smart devices on monitoring cognitive health
1 week ago
CCS1477 has a novel mechanism of action compared to existing treatments
1 week ago
Framework identifies four key priorities and five 'underpinning themes'
1 week ago
Plan aims to rapidly scale-up COVID-19 vaccination programme
Checked
1 hour 47 minutes ago
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Subscribe to Pharma times RSS Feed feed